Source: Naunyn-Schmiedeberg's Archives of Pharmacology. Unidades: FCFRP, FORP
Subjects: ANTIBIÓTICOS, FATOR DE CRESCIMENTO NEURAL DE ANIMAL, DOENÇA DE PARKINSON, FARMACOTERAPIA
ABNT
AMARAL, Lilian do et al. Doxycycline inhibits dopaminergic neurodegeneration through upregulation of axonal and synaptic proteins. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 396, n. 8, p. 1787-1796, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00210-023-02435-3. Acesso em: 19 maio 2025.APA
Amaral, L. do, Santos, N. A. G. dos, Sisti, F. M., Del Bel, E. A., & Santos, A. C. dos. (2023). Doxycycline inhibits dopaminergic neurodegeneration through upregulation of axonal and synaptic proteins. Naunyn-Schmiedeberg's Archives of Pharmacology, 396( 8), 1787-1796. doi:10.1007/s00210-023-02435-3NLM
Amaral L do, Santos NAG dos, Sisti FM, Del Bel EA, Santos AC dos. Doxycycline inhibits dopaminergic neurodegeneration through upregulation of axonal and synaptic proteins [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2023 ; 396( 8): 1787-1796.[citado 2025 maio 19 ] Available from: https://doi.org/10.1007/s00210-023-02435-3Vancouver
Amaral L do, Santos NAG dos, Sisti FM, Del Bel EA, Santos AC dos. Doxycycline inhibits dopaminergic neurodegeneration through upregulation of axonal and synaptic proteins [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2023 ; 396( 8): 1787-1796.[citado 2025 maio 19 ] Available from: https://doi.org/10.1007/s00210-023-02435-3